These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 6803699

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Model systems for the discovery and development of antiarrhythmic drugs.
    Nattel S, Duker G, Carlsson L.
    Prog Biophys Mol Biol; 2008; 98(2-3):328-39. PubMed ID: 19038282
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Bonnecor--a new anti-arrhythmia preparation].
    Berdiaev SIu, Lyskovtsev VV, Senova ZP, Darinskiĭ NV, Grigor'eva EK, Tolmacheva EA, Turilova AI, Gritsenko AN, Kaverina NV.
    Farmakol Toksikol; 1990; 53(3):33-6. PubMed ID: 2387376
    [Abstract] [Full Text] [Related]

  • 7. [Example of dose finding in practice. Pharmacology of an antiarrhythmic agent (author's transl)].
    Oberdorf A, Raschack M.
    Arzneimittelforschung; 1977 Feb; 27(2A):281-3. PubMed ID: 577176
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Search for and study of antiarrhythmic substances among crown ethers].
    Luk'ianenko NG, Bogatskiĭ AV, Iaroshenko IM, Vongaĭ VG, Nazarov EI.
    Farmakol Toksikol; 1984 Feb; 47(5):29-32. PubMed ID: 6238839
    [Abstract] [Full Text] [Related]

  • 13. [The effect of anti-arrhythmia agents on ventricular arrhythmias arising as a consequence of disorders in the myocardial blood supply].
    Gendenshteĭn EI, Kostin IaV, Markelova NN, Balashov VP, Oleĭnikov VE, Perevarin AV.
    Farmakol Toksikol; 1990 Feb; 53(4):28-30. PubMed ID: 2226754
    [Abstract] [Full Text] [Related]

  • 14. Pharmacotherapy of cardiac arrhythmias--basic science for clinicians.
    Shu J, Zhou J, Patel C, Yan GX.
    Pacing Clin Electrophysiol; 2009 Nov; 32(11):1454-65. PubMed ID: 19744278
    [Abstract] [Full Text] [Related]

  • 15. [The effect of naloxone on rhythm disorders and on the conduction system of the heart].
    Shliakhto EV, Zaĭtsev AA, Panov AV, Ardashev AV, Nifontov EM, Kashina EA, Kazarin VV, Ivanov VV.
    Eksp Klin Farmakol; 1996 Nov; 59(3):34-6. PubMed ID: 8974581
    [Abstract] [Full Text] [Related]

  • 16. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P, Tegelkamp R, Osada N, Schimpf R, Wolpert C, Breithardt G, Borggrefe M, Eckardt L.
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [Abstract] [Full Text] [Related]

  • 17. Ischemic modulation of vulnerable period and the effects of pharmacological treatment of ischemia-induced arrhythmias: a simulation study.
    Cimponeriu A, Starmer CF, Bezerianos A.
    IEEE Trans Biomed Eng; 2003 Feb; 50(2):168-77. PubMed ID: 12665030
    [Abstract] [Full Text] [Related]

  • 18. [The anti-arrhythmia activity of quinazopyrine].
    Stets VR, Beregovaia EG, Dunaev VV, Storozhuk BG, Favoritov VN, Stoliarchuk AA, Mazur AI.
    Farmakol Toksikol; 1990 Feb; 53(3):15-7. PubMed ID: 2387373
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Is there a need for new antiarrhythmic drugs?
    Roden DM.
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():13-8. PubMed ID: 8734158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.